Scott K. Aberegg, MD, MPH

Journal Article

1. Arkes HR, Aberegg SK, Arpin KA (2022). Analysis of Physicians' Probability Estimates of a Medical Outcome Based on a Sequence of Events. JAMA Netw Open, 5(6), e2218804. (Read full article)
2. Aberegg SK, Callahan SJ (2021). Common things are common, but what is common? Incorporating probability information into differential diagnosis. J Eval Clin Pract. (Read full article)
3. Aberegg SK, Wolfe BM (2021). Aspergillosis in the ICU: Hidden Enemy or Bogeyman? Am J Respir Crit Care Med, 203, 1043-1044. (Read full article)
4. Aberegg SK, Cirulis MM, Maddock SD, Freeman A, Keenan LM, Pirozzi CS, Raman SM, Schroeder J, Mann H, Callahan SJ (2020). Clinical, Bronchoscopic, and Imaging Findings of e-Cigarette, or Vaping, Product Use-Associated Lung Injury Among Patients Treated at an Academic Medical Center. JAMA Netw Open, 3(11), e2019176. (Read full article)
5. Aberegg SK, Maddock SD, Blagev DP, Callahan SJ (2020). Diagnosis of EVALI: General Approach and the Role of Bronchoscopy. Chest, 158(2), 820-827. (Read full article)
6. Aberegg SK, Johnson SA (2020). When Alternative Diagnoses Are More Likely Than Pulmonary Embolism: A Paradox. Ann Am Thorac Soc, 17(6), 670-672. (Read full article)
7. Cirulis MM, Callahan SJ, Aberegg SK (2020). Marijuana Legislation and Electronic Cigarette- or Vaping-Associated Lung Injury: A Historical Perspective. JAMA Netw Open, 3(4), e202238. (Read full article)
8. Lewis N, McCaffrey K, Sage K, Cheng CJ, Green J, Goldstein L, Campbell H, Ferrell D, Malan N, LaCross N, Maldonado A, Board A, Hanchey A, Harris D, Callahan S, Aberegg S, Risk I, Willardson S, Carter A, Nakashima A, Duncan J, Burnett C, Atkinson-Dunn R, Dunn A (2019). E-cigarette Use, or Vaping, Practices and Characteristics Among Persons with Associated Lung Injury - Utah, April-October 2019. MMWR Morb Mortal Wkly Rep, 68(42), 953-956. (Read full article)
9. Hersh AM, Walter RJ, Abberegg SK (2019). Use of Mortality as an Endpoint in Noninferiority Trials May Lead to Ethically Problematic Conclusions. J Gen Intern Med, 34(4), 618-623. (Read full article)
10. Ridgeon EE, Bellomo R, Aberegg SK, Sweeney RM, Varughese RS, Landoni G, Young PJ (2017). Effect sizes in ongoing randomized controlled critical care trials. Crit Care, 21(1), 132. (Read full article)

Editorial

1. Komorowski M, Aberegg SK (2020). Using applied lung physiology to understand COVID-19 patterns. Br J Anaesth, 125(3), 250-253. (Read full article)

Letter

1. Hendrickson K, Aberegg S (2020). Matching Minute Ventilation in Hypermetabolic State of Dinitrophenol Poisoning. [Letter to the editor]. Ann Am Thorac Soc, 17(11), 1497. (Read full article)
2. Maddock SD, Cirulis MM, Callahan SJ, Keenan LM, Pirozzi CS, Raman SM, Aberegg SK (2019). Pulmonary Lipid-Laden Macrophages and Vaping. [Letter to the editor]. N Engl J Med, 381(15), 1488-1489. (Read full article)
3. Aberegg SK, Kaufman DA (2019). Troponin in Sepsis. [Letter to the editor]. Ann Am Thorac Soc, 16(10), 1335-1336. (Read full article)
4. Aberegg SK, Carr J (2019). Carbon Dioxide Narcosis or Sleep Deprivation? [Letter to the editor]. Ann Am Thorac Soc, 16(6), 777. (Read full article)
5. Aberegg SK (2019). Post Hoc Bayesian Analyses. [Letter to the editor]. JAMA, 321(16), 1631-1632. (Read full article)

News

• Doctors Overestimate Success of Multi-Step Medical Procedures

Podcasts

• 43: Fighting COVID-19 in New York City